Aurobindo Pharma gets USFDA nod for 2 drugs
Thursday, January 1, 2009 at 4:01 am
Drug maker Aurobindo Pharma today (December 31) said it has received approvals from US drug regulator for Stavudine capsules and Stavudine oral solution, which are used in the treatment of HIV-1 infection.
The company has received nod from the US Food and Drug Administration (USFDA) for Stavudine capsules and Stavudine for oral solution used for treating HIV-1infection, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.
Further, the company has received the US regulator’s approval for Stavudine capsules in the strengths of 15 mg, 20 mg, 30 mg and 40 mg and Stavudine oral solution in 1 mg or 1 ml.
On December 22, the pharmaceutical firm had received a tentative new drug approval from USFDA for its fixed dose combination drug product Lamivudine, Zidovudine and Nevirapine tablets used in the treatment of HIV-1 infection.
Shares of the company were trading at Rs 167.05, up 3.69 per cent on the BSE.
(With inputs from Agencies)
( This post is from an independent writer. The opinions and views expressed herein are those of the author and are not endorsed by APakistanNews.Com.)
|
|
|
From World:
Got something to say?
You must be logged in to post a comment.
Todays news from Business News
- Gujarat Riots: High Court Slams Narendra Modi Govt For Failing
- Syria’s Homs Suffers ‘Heaviest’ Shelling
- Gilani Files Appeal In Contempt Case
- Maldives President Resigns After Police Revolt
- Gen. James N. Mattis Visit: US Mulling To Apologise Over Nato Attack
Advertisement
Email Subscription
Advertisement
